APA

Chapman P., Cranmer L., Dixon W. G., Hyrich K. L., Patterson J. R., Symmons D. P. M., Toporcer M. & Mastrangelo M. J. (20100317). The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit?. : Seminars in oncology.

Chicago

Chapman Paul, Cranmer Lee, Dixon W G, Hyrich K L, Patterson John R, Symmons D P M, Toporcer Mary and Mastrangelo Michael J. 20100317. The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit?. : Seminars in oncology.

Harvard

Chapman P., Cranmer L., Dixon W. G., Hyrich K. L., Patterson J. R., Symmons D. P. M., Toporcer M. and Mastrangelo M. J. (20100317). The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit?. : Seminars in oncology.

MLA

Chapman Paul, Cranmer Lee, Dixon W G, Hyrich K L, Patterson John R, Symmons D P M, Toporcer Mary and Mastrangelo Michael J. The role of anti-tumor necrosis factor receptor agents in cancer survivors: does the risk justify the benefit?. : Seminars in oncology. 20100317.